Recent News

• 09.04.2025 - Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination
• 08.21.2025 - Henry Ji, PhD
• 08.21.2025 - Stephen Ma
• 08.21.2025 - Jaisim Shah
• 08.21.2025 - Dorman Followwill
• 08.21.2025 - Alexander Wu, PhD
• 08.21.2025 - Jay Chun, MD, PhD
• 08.21.2025 - Annu Navani, MD
• 08.21.2025 - Henry Ji, PhD
• 08.21.2025 - Stephen Ma

Recent Filings

• 08.21.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.21.2025 - 8-K Current report
• 08.21.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.21.2025 - EX-99.1 EX-99.1
• 08.21.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.14.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - 424B3 Prospectus [Rule 424(b)(3)]